ICU Medical, Inc. ICUI
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -5.92% | -8.97% | -10.88% | -6.33% | -0.84% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -5.92% | -8.97% | -10.88% | -6.33% | -0.84% |
| Cost of Revenue | -9.55% | -12.41% | -14.76% | -9.51% | -6.17% |
| Gross Profit | 0.40% | -2.83% | -3.71% | -0.33% | 10.04% |
| SG&A Expenses | -1.84% | -3.62% | -2.47% | -2.12% | -0.99% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -7.04% | -9.52% | -10.97% | -7.12% | -4.50% |
| Operating Income | 13.06% | 1.05% | -9.17% | 12.25% | 181.65% |
| Income Before Tax | 25.04% | -105.45% | 123.64% | 104.80% | 126.84% |
| Income Tax Expenses | -162.22% | -158.57% | -168.82% | -95.28% | 38,183.51% |
| Earnings from Continuing Operations | 919.51% | 181.43% | 149.46% | 100.62% | 93.37% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 919.51% | 181.43% | 149.46% | 100.62% | 93.37% |
| EBIT | 13.06% | 1.05% | -9.17% | 12.25% | 181.65% |
| EBITDA | 4.23% | -1.57% | -6.94% | -2.16% | 23.23% |
| EPS Basic | 886.40% | 179.33% | 148.97% | 100.59% | 93.27% |
| Normalized Basic EPS | 71.19% | 76.28% | 115.54% | 384.65% | 168.34% |
| EPS Diluted | 843.07% | 177.20% | 148.22% | 100.45% | 92.95% |
| Normalized Diluted EPS | 70.35% | 75.59% | 114.13% | 384.38% | 168.30% |
| Average Basic Shares Outstanding | 1.11% | 1.04% | 0.94% | 1.04% | 1.20% |
| Average Diluted Shares Outstanding | 1.66% | 1.45% | 1.43% | 1.10% | 1.27% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |